April19 is a drug development company that integrates AI with computational chemistry to design and develop psychedelic-inspired compounds for various therapeutic indications, including neurodegenerative disorders and healthy longevity. The company focuses on expanding the utility of psychedelics beyond mental health by optimizing their pharmacology.

April19 Discovery Inc

Primordial AI utilizes evolutionary data and artificial intelligence to discover drug targets, focusing on achieving next-generation drug development.

Primordial AI

April19 Discovery | 552 followers on LinkedIn. AI-driven psychedelic drug discovery | We use next-gen machine learning to find novel psychedelic drug compounds. Classical (first-generation) psychedelics have never been optimized to treat any disease and so we aim to design compounds with the optimal risk-benefit ratio in various indications. Beyond mental health, we focus on neurodegeneration and neural injuries, increasing brain longevity and extending human mental healthspan.

AI-driven drug discovery

Richard Dallaway

I give business owners more hours in the day - by outsourcing your business support to me creating time for YOU to smash those goals. Concierge |…

Jill Hartery

Founder & Business Lawyer at Britannia Law Corporation

Miles Gelmon

April19 Discovery

Ten years of cognitive decline reversed, cognitive scores increased by 57%, Alzheimer's diagnosis formally retracted... What a magnificent display of the power of psychedelics in treating neurodegenerative disorders. We are feeling truly blessed to see this hands-on confirmation that our development efforts are going very much in the right direction. We thank Chelsea R. and Cody Shirk from Spannr - End-to-End Longevity. who had wisely seen the potential of the compounds we are pursuing for treating neurodegeneration and advancing the quest for healthy longevity. And of course, Adam Tapp , the hero of this story, and of our time. Alzheimer's Society Alzheimer's Association® Mapping Alzheimer's Alzheimer's Readiness Project Alzheimer's Disease Research Alzheimer Nederland Alzheimer Society of Ireland Alzheimer's Association WNY Chapter Events Alzheimer's Products Australia American Alzheimer's Research Organization Alzheimer's Family Center Alzheimer's Drug Discovery Foundation Alzheimer's Care Specialists Alzheimer Society of Canada Société Alzheimer D. Alzheimers Family Organization #drugdiscovery #drugdevelopment #Alzheimer #neurodegeneration # #development #longevity #lifespan

Watch our CEO's lecture on using psychedelics in dementia treatment! (currently Czech only - comment if interested in English subtitles) #psychedelics #dementia #longevity #neurodegeneration #psychedelictherapy #Alzheimers

To our Czech followers - do not miss April19 CEO Jáchym Fibír giving a lecture about the development of revolutionary #psychedelic therapies for #neurodegeneration and #dementia at the Faculty of Philosophy, Charles University in Prague!

Metric
Company Name	April19 Discovery Inc	Primordial AI
Symbol
MSH ID	AI:APRIL19	COM:PRIMORDIALBIO
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services
Industry	Biotechnology	Biotechnology
Country	US	US
Stage
Employee Count
Website	april19.ai	primordialbio.com
LinkedIn	april19ai	primordial-ai
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

APRI

AI:APRIL19

April19 Discovery Inc

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue